Related references
Note: Only part of the references are listed.Analysis of the inhibiting activity of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) on matrix metalloproteinases
Soraia R. Mendes et al.
SCIENTIFIC REPORTS (2020)
Activity of MCPIP1 RNase in tumor associated processes
Katarzyna Miekus et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Saray Quintero-Fabian et al.
FRONTIERS IN ONCOLOGY (2019)
miR-4521-FAM129A axial regulation on ccRCC progression through TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways
Xue Feng et al.
CELL DEATH DISCOVERY (2019)
RNA sequencing reveals widespread transcriptome changes in a renal carcinoma cell line
Agata Lichawska-Cieslar et al.
Oncotarget (2018)
MCPIP1 Exogenous Overexpression Inhibits Pathways Regulating MYCN Oncoprotein Stability in Neuroblastoma
Elzbieta Boratyn et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression
Paulina Marona et al.
CANCER RESEARCH (2017)
MCPIP1 contributes to clear cell renal cell carcinomas development
Janusz Ligeza et al.
ANGIOGENESIS (2017)
Monocyte Chemoattractant Protein-Induced Protein 1 Overexpression Modulates Transcriptome, Including MicroRNA, in Human Neuroblastoma Cells
Elzbieta Boratyn et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression
Wenbao Lu et al.
CANCER RESEARCH (2016)
Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis
Qiang Fu et al.
BRITISH JOURNAL OF CANCER (2015)
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Ghislaine Scelo et al.
NATURE COMMUNICATIONS (2014)
Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis
Anja Rabien et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma
Hongsheng Lu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Loss of TIMP-3 Promotes Tumor Invasion via Elevated IL-6 Production and Predicts Poor Survival and Relapse in HPV-Infected Non-Small Cell Lung Cancer
De-Wei Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Metastatic potential of a renal mass according to original tumour size at presentation
Eric C. Umbreit et al.
BJU INTERNATIONAL (2012)
The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases
Cuijian Zhang et al.
BJU INTERNATIONAL (2012)
MCPIP1 Ribonuclease Antagonizes Dicer and Terminates MicroRNA Biogenesis through Precursor MicroRNA Degradation
Hiroshi I. Suzuki et al.
MOLECULAR CELL (2011)
TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells
M. C. Anania et al.
ONCOGENE (2011)
Loss of expression of TIMP3 in clear cell renal cell carcinoma
Damien Masson et al.
EUROPEAN JOURNAL OF CANCER (2010)
MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling
Jian Liang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Regulatory feedback loop between NF-κB and MCP-1-induced protein 1 RNase
Lukasz Skalniak et al.
FEBS JOURNAL (2009)
Interleukin-1-inducible MCPIP protein has structural and functional properties of RNase and participates in degradation of IL-1β mRNA
Danuta Mizgalska et al.
FEBS JOURNAL (2009)
Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
Kazufumi Matsushita et al.
NATURE (2009)
Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays
Jolanta Jura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo
Chong-Keng Chang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Activation of PI3K is associated with reduced survival in renal cell carcinoma
Axel S. Merseburger et al.
UROLOGIA INTERNATIONALIS (2008)
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer
K Takenaka et al.
EUROPEAN JOURNAL OF CANCER (2004)
A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2
JH Qi et al.
NATURE MEDICINE (2003)
Loss of tumor suppressor protein PTEN during renal carcinogenesis
W Brenner et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis
J Oh et al.
CELL (2001)
Share Paper
